The Discounted Cash Flow (DCF) valuation of Theradiag SA (ALTER.PA) is (2.26) EUR. With the latest stock price at 1.26 EUR, the upside of Theradiag SA based on DCF is -279.7%.
Based on the latest price of 1.26 EUR and our DCF valuation, Theradiag SA (ALTER.PA) is a sell. selling ALTER.PA stocks now will result in a potential gain of 279.7%.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| WACC / Discount Rate | 5.0% - 6.4% | 5.7% |
| Long-term Growth Rate | 3.0% - 4.7% | 3.9% |
| Fair Price | (18.24) - (1.10) | (2.26) |
| Upside | -1547.6% - -187.2% | -279.7% |